Cargando…

Immunotherapy in HPV-Related Oropharyngeal Cancers

Human papillomavirus (HPV)–related oropharyngeal squamous cell carcinoma (OPSCC) incidence has been increasing in recent decades. Treatment of the locally advanced HPV-related OPSCC includes a multidisciplinary approach. Immunotherapy with immune checkpoint inhibitors is used in the treatment of pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roof, Logan, Yilmaz, Emrullah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2023
Materias:	Head and Neck Cancer (AJ Rosenberg, Section Editor)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887557/ https://www.ncbi.nlm.nih.gov/pubmed/36719604 http://dx.doi.org/10.1007/s11864-023-01050-x

Ejemplares similares

Treatment Considerations for Patients with Locoregionally Advanced Head and Neck Cancer with a Contraindication to Cisplatin
por: Kim, Sangwoo S., et al.
Publicado: (2023)

Preservation of swallowing function with de-intensified chemoradiation therapy for HPV-associated oropharyngeal squamous cell carcinoma
por: Judy, Greg D., et al.
Publicado: (2018)

Stem cell markers in oral and oropharyngeal squamous cell carcinomas in relation to the site of origin and HPV infection: clinical implications
por: Rizzo, Davide, et al.
Publicado: (2020)

A comparison between p16-positive head and neck cancer of unknown primary (HPV-HNCUP) and oropharyngeal squamous cell carcinoma (HPV-OPSCC): are they the same disease?
por: Balk, Matthias, et al.
Publicado: (2023)

Prognostic impact of additional HPV diagnostics in 102 patients with p16-stratified advanced oropharyngeal squamous cell carcinoma
por: Weiss, Bernhard G., et al.
Publicado: (2020)

Proton Therapy for HPV-Associated Oropharyngeal Cancers of the Head and Neck: a De-Intensification Strategy
por: Taku, Nicolette, et al.
Publicado: (2021)

Emotional Quality of Life After Radiation Therapy for Oropharyngeal Carcinoma
por: Rajeev-Kumar, Greeshma, et al.
Publicado: (2019)

Costs of oropharyngeal squamous cell cancer treatment in Finland
por: Tikkanen, Juhana, et al.
Publicado: (2023)

Upfront transoral robotic surgery (TORS) versus intensity-modulated radiation therapy (IMRT) in HPV-positive oropharyngeal cancer: real-world data from a tertiary comprehensive cancer centre
por: Zorzi, Stefano Filippo, et al.
Publicado: (2022)

Radiation-Induced Hypothyroidism After Radical Intensity Modulated Radiation Therapy for Oropharyngeal Carcinoma
por: Kamal, Mona, et al.
Publicado: (2019)

Comparison of the Seventh and Eighth Edition of American Joint Committee on Cancer (AJCC) Staging for Selected and Nonselected Oropharyngeal Squamous Cell Carcinomas
por: Vijayvargiya, Pooja, et al.
Publicado: (2022)

p16, HPV, and Cetuximab: What Is the Evidence?
por: Bonner, James A., et al.
Publicado: (2017)

Management of clinically N0 neck in oropharyngeal carcinoma
por: Jouhi, Lauri, et al.
Publicado: (2019)

The evolving landscape of human papillomavirus-related oropharyngeal squamous cell carcinoma at a single institution in Northern Italy
por: MORBINI, P., et al.
Publicado: (2019)

Unravelling the risk factors that underlie oral and oropharyngeal surgery in elderly
por: MOLTENI, G., et al.
Publicado: (2018)

Incidental uptake of fluorodeoxyglucose in the Waldeyer’s ring and risk of oropharyngeal malignancy
por: Bujoreanu, Iulia, et al.
Publicado: (2021)

Standard chemoradiation versus intensity-modulated chemoradiation: a quality of life assessment in oropharyngeal cancer patients
por: Mowry, Sarah E., et al.
Publicado: (2009)

Bilateral versus ipsilateral neck dissection in oral and oropharyngeal cancer with contralateral cN0 neck
por: Knopf, Andreas, et al.
Publicado: (2020)

The accuracy of clinical neck staging for p16-positive and negative oropharyngeal cancer and its therapeutic implications
por: Hussain, Timon, et al.
Publicado: (2022)

Surgery and postoperative radiotherapy a valid treatment for advanced oropharyngeal carcinoma
por: Lybak, Stein, et al.
Publicado: (2010)

Cost analysis in oral cavity and oropharyngeal reconstructions with microvascular and pedicled flaps
por: DEGANELLO, A., et al.
Publicado: (2013)

Comparison of PD-L1 expression in squamous cell cancer of unknown primary and oropharyngeal squamous cell carcinoma
por: Schmidl, Benedikt, et al.
Publicado: (2022)

Is HPV‐Associated Oropharyngeal Cancer Becoming More Common in Older Patients?
por: Thompson, James D., et al.
Publicado: (2018)

Development of a prognostic model of overall survival in oropharyngeal cancer from real-world data: PRO.M.E.THE.O.
por: Miccichè, Francesco, et al.
Publicado: (2022)

Trans-oral robotic surgery for the management of oropharyngeal carcinomas: a 9-year institutional experience
por: MECCARIELLO, G., et al.
Publicado: (2019)

Staging and prognosis of oropharyngeal carcinoma according to the 8th Edition of the American Joint Committee on Cancer Staging Manual in human papillomavirus infection
por: Yamashita, Yukashi, et al.
Publicado: (2018)

Impact of HPV infection on the clinical outcome of p-CAIR trial in head and neck cancer
por: Snietura, Miroslaw, et al.
Publicado: (2010)

Intraoperative free margins assessment of oropharyngeal squamous cell carcinoma with confocal laser endomicroscopy: a pilot study
por: Sievert, Matti, et al.
Publicado: (2021)

Modified submental platysmal adipomyofascial flap: is it a reliable alternate reconstructive option for small- to mid-sized defects especially in male patients with oral/oropharyngeal cancer?
por: Singh, Abhishek, et al.
Publicado: (2020)

Cancer stage and pack-years, but not p16 or HPV, are relevant for survival in hypopharyngeal and laryngeal squamous cell carcinomas
por: Dahm, Valerie, et al.
Publicado: (2018)

Comparison of PI3K Pathway in HPV‐Associated Oropharyngeal Cancer With and Without Tobacco Exposure
por: Kiessling, Si‐Young, et al.
Publicado: (2018)

Outcomes following oropharyngeal squamous cell carcinoma resection and bilateral neck dissection with or without contralateral postoperative radiotherapy of the pathologically node-negative neck
por: Jansen, Florian, et al.
Publicado: (2023)

The role of the innate and adaptive immune response in HPV‐associated oropharyngeal squamous cell carcinoma
por: Subbarayan, Rahul Sridhar, et al.
Publicado: (2019)

Comparison of p53, HSP90, E-cadherin and HPV in oral lichen planus and oral squamous cell carcinoma
por: Bar, Julia K., et al.
Publicado: (2021)

The prognostic-nutritional index in HPV-negative head and neck squamous cell carcinoma treated with upfront surgery: a multi-institutional series
por: Tomasoni, Michele, et al.
Publicado: (2023)

Prognostic Value of Radiologic Extranodal Extension in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma
por: Lee, Boeun, et al.
Publicado: (2019)

PET/MR versus PET/CT for locoregional staging of oropharyngeal squamous cell cancer
por: Flygare, Lennart, et al.
Publicado: (2022)

Oropharyngeal cancer: Monday 3 October 2005, 14:00–16:00
por: Hermans, Robert
Publicado: (2005)

The relation between hypoxia and proliferation biomarkers with radiosensitivity in locally advanced laryngeal cancer
por: van den Bovenkamp, Karlijn, et al.
Publicado: (2023)

Does 5 + 5 Equal Better Radiation Treatment Plans in Head and Neck Cancers?
por: Corkum, Mark T., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_c5joccsq0q1j1lr3m7tojp38nc